https://www.avera.org/research-and-clinical-trials/clinical-trials/detail/?id=297
EAP Obe-cel (AUTO1-OS1): Expanded Access Program (EAP) for Obecabtagene Autoleucel (obe-cel)...
Expanded Access Program (EAP) for Obecabtagene Autoleucel (obe-cel) Out-of-specification (OOS) in Adult Patients with Acute Lymphoblastic Leukemia
expanded access programeapobecel
https://research.luriechildrens.org/en/clinical-studies-search/vx-445teziva-expanded-access-program-for-cystic-fibrosis-cf-patients-heterozygous-for-f508del-mutation-and-a-minimal-function-mutation-fmf-genotypes2/
VX-445/TEZ/IVA Expanded Access Program for Cystic Fibrosis (CF) Patients Heterozygous for F508del...
expanded access programcystic fibrosisvxteziva
https://curemydisease.com/studies/pompe-disease-expanded-access-program-nct03865836-419
Pompe Disease Expanded Access Program (NCT03865836)
Expanded access to ATB200/AT2221 for Pompe disease patients not eligible for clinical trials or declining standard therapy. NCT ID: NCT03865836.
expanded access programpompe disease
https://www.mayo.edu/research/clinical-trials/cls-20580815
Expanded Access Program Of AMTAGVI That Is Out Of Specification For Commercial Release - Mayo Clinic
Learn more about services at Mayo Clinic.
expanded access programis outfor commercialmayo clinicamtagvi